These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 2577965

  • 21. Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans.
    Accili D, Barbetti F, Cama A, Kadowaki H, Kadowaki T, Imano E, Levy-Toledano R, Taylor SI.
    J Invest Dermatol; 1992 Jun; 98(6 Suppl):77S-81S. PubMed ID: 1588128
    [Abstract] [Full Text] [Related]

  • 22. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H, Toyota T, Okuguchi F, Umezu M, Kai Y, Abe R, Maruhama Y, Goto Y, Hanew K, Utsumi N.
    Nihon Naika Gakkai Zasshi; 1980 Mar 10; 69(3):361-9. PubMed ID: 7381285
    [No Abstract] [Full Text] [Related]

  • 23. Insulin resistance with acanthosis nigricans and acral hypertrophy.
    Holdaway IM, Frengley PA, Graham FM, Wong M.
    N Z Med J; 1984 May 09; 97(755):286-8. PubMed ID: 6587221
    [Abstract] [Full Text] [Related]

  • 24. Polypeptide hormones: pathology and clinical aspects.
    Van Obberghen E.
    Acta Histochem Suppl; 1984 May 09; 29():51-5. PubMed ID: 6425926
    [No Abstract] [Full Text] [Related]

  • 25. Morfan: a new syndrome characterized by mental retardation, pre- and postnatal overgrowth, remarkable face and acanthosis nigricans in 5-year-old boy.
    Seemanová E, Rüdiger HW, Dreyer M.
    Am J Med Genet; 1993 Feb 15; 45(4):525-8. PubMed ID: 8465862
    [No Abstract] [Full Text] [Related]

  • 26. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K, Pankratz K, Cathey V, Immohotichey P, Maddox J, Felton B, McIntosh R, Parker D, Burgin C, Blackett P.
    J Okla State Med Assoc; 2006 Jan 15; 99(1):19-24. PubMed ID: 16499154
    [Abstract] [Full Text] [Related]

  • 27. [Physiologic and physiopathologic implications of insulin-receptor interaction (III)].
    Durán García S, González Mateo MC.
    Med Clin (Barc); 1984 May 05; 82(17):771-6. PubMed ID: 6429461
    [No Abstract] [Full Text] [Related]

  • 28. Four mutant alleles of the insulin receptor gene associated with genetic syndromes of extreme insulin resistance.
    Kadowaki H, Takahashi Y, Ando A, Momomura K, Kaburagi Y, Quin JD, MacCuish AC, Koda N, Fukushima Y, Taylor SI, Akanuma Y, Yazaki Y, Kadowaki T.
    Biochem Biophys Res Commun; 1997 Aug 28; 237(3):516-20. PubMed ID: 9299395
    [Abstract] [Full Text] [Related]

  • 29. [Insulin resistance due to genetic defects of insulin receptors].
    Kuzuya H, Yoshimasa Y, Kakehi T, Kosaki A, Imura H.
    Nihon Rinsho; 1989 Oct 28; 47(10):2403-8. PubMed ID: 2607636
    [No Abstract] [Full Text] [Related]

  • 30. Insulin action and inaction.
    Taylor SI.
    Clin Res; 1987 Sep 28; 35(5):459-72. PubMed ID: 3311568
    [No Abstract] [Full Text] [Related]

  • 31. [Abnormal insulin receptor type-B associated with lupus erythematosus].
    Saito N, Usami K, Miyazaki M, Nishimaki T, Yoshida H, Kasukawa R, Asano S, Kamiyama S, Wakasa H, Goto K.
    Nihon Rinsho; 1983 Oct 28; 41(10):2412-20. PubMed ID: 6668704
    [No Abstract] [Full Text] [Related]

  • 32. [Mutations in the insulin receptor gene].
    Hashiramoto M, Kasuga M.
    Nihon Rinsho; 2002 Jul 28; 60 Suppl 7():642-7. PubMed ID: 12238112
    [No Abstract] [Full Text] [Related]

  • 33. Familial acanthosis nigricans. A longitudinal study.
    Friedman CI, Richards S, Kim MH.
    J Reprod Med; 1987 Jul 28; 32(7):531-6. PubMed ID: 3305929
    [Abstract] [Full Text] [Related]

  • 34. Association of specific histocompatibility antigens and acanthosis nigricans with insulin resistance.
    Saad MJ, Monteiro CM, Eizirik DL, Foss MC.
    Braz J Med Biol Res; 1990 Jul 28; 23(10):959-64. PubMed ID: 2101060
    [Abstract] [Full Text] [Related]

  • 35. [Molecular genetics of insulin receptor and its disorder].
    Makino H, Taira M, Hashimoto N, Shimada F, Suzuki Y, Yoshida S, Ebina Y.
    Nihon Rinsho; 1989 Oct 28; 47(10):2299-304. PubMed ID: 2575181
    [No Abstract] [Full Text] [Related]

  • 36. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG, Maldonado M, Oral E, Balasubramanyam A.
    Metabolism; 2007 May 28; 56(5):670-5. PubMed ID: 17445543
    [Abstract] [Full Text] [Related]

  • 37. Syndromes associated with insulin resistance and acanthosis nigricans.
    Taylor SI, Arioglu E.
    J Basic Clin Physiol Pharmacol; 1998 May 28; 9(2-4):419-39. PubMed ID: 10212846
    [No Abstract] [Full Text] [Related]

  • 38. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS, Johnson JL, Elliott-Mills D, Opas LM.
    Lupus; 1997 May 28; 6(3):275-8. PubMed ID: 9104736
    [Abstract] [Full Text] [Related]

  • 39. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL.
    Diabetologia; 2002 May 28; 45(5):657-67. PubMed ID: 12107746
    [Abstract] [Full Text] [Related]

  • 40. Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation.
    Boor R, Herwig J, Schrezenmeir J, Pontz BF, Schönberger W.
    Am J Med Genet; 1993 Mar 01; 45(5):649-53. PubMed ID: 8456839
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.